Literature DB >> 33524140

DeCompress: tissue compartment deconvolution of targeted mRNA expression panels using compressed sensing.

Arjun Bhattacharya1, Alina M Hamilton2, Melissa A Troester2,3, Michael I Love4,5.   

Abstract

Targeted mRNA expression panels, measuring up to 800 genes, are used in academic and clinical settings due to low cost and high sensitivity for archived samples. Most samples assayed on targeted panels originate from bulk tissue comprised of many cell types, and cell-type heterogeneity confounds biological signals. Reference-free methods are used when cell-type-specific expression references are unavailable, but limited feature spaces render implementation challenging in targeted panels. Here, we present DeCompress, a semi-reference-free deconvolution method for targeted panels. DeCompress leverages a reference RNA-seq or microarray dataset from similar tissue to expand the feature space of targeted panels using compressed sensing. Ensemble reference-free deconvolution is performed on this artificially expanded dataset to estimate cell-type proportions and gene signatures. In simulated mixtures, four public cell line mixtures, and a targeted panel (1199 samples; 406 genes) from the Carolina Breast Cancer Study, DeCompress recapitulates cell-type proportions with less error than reference-free methods and finds biologically relevant compartments. We integrate compartment estimates into cis-eQTL mapping in breast cancer, identifying a tumor-specific cis-eQTL for CCR3 (C-C Motif Chemokine Receptor 3) at a risk locus. DeCompress improves upon reference-free methods without requiring expression profiles from pure cell populations, with applications in genomic analyses and clinical settings.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33524140      PMCID: PMC8096278          DOI: 10.1093/nar/gkab031

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  112 in total

1.  A linear complexity phasing method for thousands of genomes.

Authors:  Olivier Delaneau; Jonathan Marchini; Jean-François Zagury
Journal:  Nat Methods       Date:  2011-12-04       Impact factor: 28.547

2.  Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses.

Authors:  Ruijie Liu; Aliaksei Z Holik; Shian Su; Natasha Jansz; Kelan Chen; Huei San Leong; Marnie E Blewitt; Marie-Liesse Asselin-Labat; Gordon K Smyth; Matthew E Ritchie
Journal:  Nucleic Acids Res       Date:  2015-04-29       Impact factor: 16.971

3.  HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.

Authors:  Aleix Prat; Tomás Pascual; Carmine De Angelis; Carolina Gutierrez; Antonio Llombart-Cussac; Tao Wang; Javier Cortés; Brent Rexer; Laia Paré; Andres Forero; Antonio C Wolff; Serafín Morales; Barbara Adamo; Fara Brasó-Maristany; Maria Vidal; Jamunarani Veeraraghavan; Ian Krop; Patricia Galván; Anne C Pavlick; Begoña Bermejo; Miguel Izquierdo; Vanessa Rodrik-Outmezguine; Jorge S Reis-Filho; Susan G Hilsenbeck; Mafalda Oliveira; Maria Vittoria Dieci; Gaia Griguolo; Roberta Fasani; Paolo Nuciforo; Joel S Parker; PierFranco Conte; Rachel Schiff; Valentina Guarneri; C Kent Osborne; Mothaffar F Rimawi
Journal:  J Natl Cancer Inst       Date:  2020-01-01       Impact factor: 13.506

4.  Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.

Authors:  Shannon A Bryan; Peter J Jose; Joanna R Topping; Robert Wilhelm; Carol Soderberg; Denis Kertesz; Peter J Barnes; Timothy J Williams; Trevor T Hansel; Ian Sabroe
Journal:  Am J Respir Crit Care Med       Date:  2002-06-15       Impact factor: 21.405

5.  Estimation of blood cellular heterogeneity in newborns and children for epigenome-wide association studies.

Authors:  Paul Yousefi; Karen Huen; Hong Quach; Girish Motwani; Alan Hubbard; Brenda Eskenazi; Nina Holland
Journal:  Environ Mol Mutagen       Date:  2015-08-31       Impact factor: 3.216

6.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

7.  Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures.

Authors:  Konstantin Zaitsev; Monika Bambouskova; Amanda Swain; Maxim N Artyomov
Journal:  Nat Commun       Date:  2019-05-17       Impact factor: 14.919

8.  A framework for transcriptome-wide association studies in breast cancer in diverse study populations.

Authors:  Arjun Bhattacharya; Montserrat García-Closas; Andrew F Olshan; Charles M Perou; Melissa A Troester; Michael I Love
Journal:  Genome Biol       Date:  2020-02-20       Impact factor: 13.583

9.  Digital sorting of complex tissues for cell type-specific gene expression profiles.

Authors:  Yi Zhong; Ying-Wooi Wan; Kaifang Pang; Lionel M L Chow; Zhandong Liu
Journal:  BMC Bioinformatics       Date:  2013-03-07       Impact factor: 3.169

10.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.

Authors:  Dvir Aran; Agnieszka P Looney; Leqian Liu; Esther Wu; Valerie Fong; Austin Hsu; Suzanna Chak; Ram P Naikawadi; Paul J Wolters; Adam R Abate; Atul J Butte; Mallar Bhattacharya
Journal:  Nat Immunol       Date:  2019-01-14       Impact factor: 25.606

View more
  1 in total

1.  CancerSCEM: a database of single-cell expression map across various human cancers.

Authors:  Jingyao Zeng; Yadong Zhang; Yunfei Shang; Jialin Mai; Shuo Shi; Mingming Lu; Congfan Bu; Zhewen Zhang; Zaichao Zhang; Yang Li; Zhenglin Du; Jingfa Xiao
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.